Asker Healthcare Group AB (CHIX:ASKERS) ROCE %: 12.46% (As of Mar. 2026)


CHIX:ASKERS Asker Healthcare Group AB CHIX:ASKERS
20 GF Score
Price kr77.50
! 3 Warning Signs
View Full Analysis

What is Asker Healthcare Group AB ROCE %?

Asker Healthcare Group AB CHIX:ASKERS 20 ROCE % is 12.46% as of Mar. 2026. GuruFocus rates CHIX:ASKERS with a GF Score™ of 20/100. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Asker Healthcare Group AB's annualized ROCE % for the quarter that ended in Mar. 2026 was 12.46%.


Asker Healthcare Group AB  (CHIX:ASKERs) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Asker Healthcare Group AB ROCE % Related Terms


Asker Healthcare Group AB ROCE % Historical Data

* Premium members only.

The historical data trend for Asker Healthcare Group AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asker Healthcare Group AB ROCE % Chart

Asker Healthcare Group AB Annual Data
Trend Dec22 Dec23 Dec24 Dec25
ROCE %
9.01 6.95 9.37 7.68

Asker Healthcare Group AB Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 15.17 8.76 9.91 9.19 12.46
CHIX:ASKERS
20GF Score
Asker Healthcare Group AB CHIX:ASKERS
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asker Healthcare Group AB ROCE % Calculation

Asker Healthcare Group AB's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=870/( ( (13118 - 3198) + (16774 - 4037) )/ 2 )
=870/( (9920+12737)/ 2 )
=870/11328.5
=7.68 %

Asker Healthcare Group AB's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=1620/( ( (16774 - 4037) + (17753 - 4477) )/ 2 )
=1620/( ( 12737 + 13276 )/ 2 )
=1620/13006.5
=12.46 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 12.46% mean?
Asker Healthcare Group AB (CHIX:ASKERS) has a ROCE % of 12.46% as of Mar. 2026.
Is Asker Healthcare Group AB's ROCE % too high?
Asker Healthcare Group AB's current ROCE % is 12.46%. The Medical Distribution industry median ROCE % is 8.92. Asker Healthcare Group AB's value of 12.46% is 39.7% above this industry median. Overall, Asker Healthcare Group AB has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Asker Healthcare Group AB's ROCE % compare to MCK and CAH?
Asker Healthcare Group AB's ROCE % of 12.46% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 8.92. Asker Healthcare Group AB's value of 12.46% is 39.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 8.92, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asker Healthcare Group AB's current ROCE % of 12.46% is 39.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 8.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asker Healthcare Group AB's current ROCE % is 12.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asker Healthcare Group AB stock overvalued right now?
Asker Healthcare Group AB (CHIX:ASKERS) has a current ROCE % of 12.46%. The current ROCE % is 12.46% and 39.7% above the Medical Distribution industry median of 8.92. Asker Healthcare Group AB's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Asker Healthcare Group AB (CHIX:ASKERS), the current ROCE % is 12.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Asker Healthcare Group AB Business Description

Other Exchanges ASKER:SwedenI88:Germany
Address Svardvagen 3A, Danderyd, SWE, 182 33
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
20GF Score

Get the complete analysis for CHIX:ASKERS

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr77.50
Price